ISMRC 2023 Final Programme

32 PS-06-006 Detection of multiple HPV types in liq- uid biopsies of cervical neoplasia Katharina Harms-Effenberger, Germany PS-06-007 Impact of reference materials for ana- lytical performance evaluation of liquid biopsy NGS assays Ariane Hallermayr, Germany PS-06-008 Feasibility and efficacy of adjuvant che- motherapy in stage II colon cancer pa- tients with detectable circulating tumor DNA after surgery Ingrid Franken, The Netherlands PS-06-009 ExTarget– Circulating tumor DNA pro- filing for response assessment and MRD monitoring in molecular tumor board patients Stephanie Fliedner, Germany PS-06-010 Monitoring the release of tumor cells before, during and after prostatectomy Gresa Emurlai, Germany PS-06-011 Performance of ddPCR and qPCR to detect cell-free HPV16 DNA in liquid biopsies from patients with HPV-related oropharyngeal squamous cell carcinoma at diagnosis and recurrence Imke Demers, The Netherlands PS-06-012 Cell-free tumor DNA analysis during immunotherapy to monitor clinical re- sponse for patients with non-small cell lung cancer Anna Rohlin, Sweden PS-06-013 UCCSH NGSP: Improvement of molec- ular tumor board decisions with a ctD- NA-based deep scale cross-entity NGS panel Eva Dazert-Klebsattel, Germany PS-06-014 Evaluation of a multi-omics approach to molecular residual disease detection Archana Ramesh, United States PS-06-015 Exploring the clinical relevance of cir- culating tumor cells and tumor-derived extracellular vesicles collected from dif- ferent blood compartments in colorectal cancer patients Stefan Cieslik, Germany PS-06-016 A Targeted-enzymatic-methyl-seq ap- proach for cell-free DNA methylation analysis to improve cancer detection, disease following and minimal residual disease monitoring Mehdi Ben Sassi, France PS-06-017 Identification of atypical cells in the blood of non-small cell lung cancer (NSCLC) patients Yassine Belloum, Germany PS-06-018 Integrated circulating tumor DNA and cytokine analysis for therapy monitor- ing of ALK-rearranged lung adenocar- cinoma Arlou Kristina Angeles, Germany Poster Sessions – Wednesday, 3 May 2023